Abstract Details

Title Migraine-Related Stigma in Adults With Current Versus Previous High-Frequency Migraine and Acute Medication Overuse: Results of the Harris Poll Migraine Report Card Survey

Topic Headache

Presentation(s) P7 - Poster Session 7 (8:00 AM-9:00 AM)

Poster/Presentation
Number 2-010

Objective

To evaluate self-reported stigma in US adults with high-frequency headache/migraine (HFM) and acute medication overuse (AMO).

Background

While the increasing frequency of migraine is associated with greater disability and comorbidities, data of stigma relating to HFM+AMO are limited.

Design/Methods

US adults (≥18yr) who screened positive for migraine on the validated “ID Migraine” completed a 15-minute online survey. Respondents were classified into “current HFM+AMO” (≥8 days/month with headache/migraine with ≥10 days/month of acute headache medication use) or “previous HFM+AMO” (previously experienced HFM, but currently experiencing headache ≤7 days/month with ≤9 days/month of acute medication use). The 8-item Stigma Scale for Chronic Illnesses (SSCI-8) assessed internal and external stigma. Statistically significant differences were detected by standard t-test at 90% and 95% confidence levels.

Results US adults (N=550) were classified as having current (n=440, 54% women, mean age 41.1yr, 57% White) or previous (n=110, 49% women, mean age 47.2yr, 75% White) HFM+AMO. Adults with current HFM+AMO were more likely than those with previous HFM+AMO to always/often experience 6 of 8 SSCI-8 measures (P<0.1). Women with current HFM+AMO were more likely than women with previous HFM+AMO to always/often experience 7 SSCI-8 measures (P<0.1). Of those with current HFM+AMO, men were more likely than women to always/often feel embarrassed about their illness, feel people avoided looking at them, and say people were unkind to them (P<0.1); younger respondents (18-49yr) were more likely than older respondents (≥50yr) to always/often experience 6 SSCI-8 measures (P<0.1); and Black respondents were more likely than white respondents to always/often feel embarrassed and feel that people were unkind to them (P<0.1).

Conclusions

US adults with current HFM+AMO were more likely to experience stigma due to migraine than those with previous HFM+AMO, particularly women. Certain stigma experiences were significantly more common in men, younger adults, and Black adults with current HFM+AMO.

Authors/Disclosures
Divya Asher PRESENTER	Divya Asher has received personal compensation for serving as an employee of Lundbeck. Divya Asher has received personal compensation for serving as an employee of AbbVie.
Dawn C. Buse, PhD (Dawn C. Buse, PhD)	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Roger Cady, MD (RK Consulting, LLC)	Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Amaal J. Starling, MD, FAAN (Mayo Clinic)	Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
	No disclosure on file
	No disclosure on file
	No disclosure on file
Steven Kymes	Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.

��ɫ��

��ɫ��